Adjuvanted influenza vaccines
In spite of current influenza vaccines being immunogenic, evolution of the influenza virus can reduce efficacy and so influenza remains a major threat to public health. One approach to improve influenza vaccines is to include adjuvants; substances that boost the immune response. Adjuvants are partic...
Saved in:
Main Authors: | John S. Tregoning (Author), Ryan F. Russell (Author), Ekaterina Kinnear (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2018-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Promising Adjuvants and Platforms for Influenza Vaccine Development
by: Wandi Zhu, et al.
Published: (2021) -
Evaluating α-galactosylceramide as an adjuvant for live attenuated influenza vaccines in pigs
by: Bianca L. Artiaga, et al.
Published: (2022) -
The cost-effectiveness of an adjuvanted quadrivalent influenza vaccine in the United Kingdom
by: Michele A. Kohli, et al.
Published: (2021) -
Development of novel cationic microemulsion as parenteral adjuvant for influenza vaccine
by: Sakalanunt Lamaisakul, et al.
Published: (2020) -
Development of MF-59 adjuvant using chitosan derivatives to influenza vaccine
by: Alireza Loghmani, et al.
Published: (2020)